Adipose-tissue regulatory T cells: Critical players in adipose-immune crosstalk

European Journal of Immunology

Volumn 47, Issue 11, 2017, Pages 1867-1874

  Becker, Maike ^a,b   Levings, Megan K ^c   Daniel, Carolin ^a,b  

^a INSTITUTE OF EPIDEMIOLOGY   (Germany)

^b GERMAN CENTER FOR DIABETES RESEARCH DZD   (Germany)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Adipose tissue function; FoxP3; IL 33; Immune adipose crosstalk; Regulatory T cells (Tregs); Type 2 diabetes; T cell tolerance

Indexed keywords

INTERLEUKIN 1 RECEPTOR LIKE 1 PROTEIN; INTERLEUKIN 33;

ADIPOCYTE; ADIPOSE TISSUE; HUMAN; INFLAMMATION; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN INTERACTION; REGULATORY T LYMPHOCYTE; REVIEW; T LYMPHOCYTE; ANIMAL; IMMUNOLOGY; MOUSE; SIGNAL TRANSDUCTION;

ADIPOSE TISSUE; ANIMALS; DIABETES MELLITUS, TYPE 2; HUMANS; MICE; OBESITY; RECEPTOR CROSS-TALK; T-LYMPHOCYTES, REGULATORY;

EID: 85030096902     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201646739     Document Type: Review

References (81)

1. Shoelson, S. E., Lee, J. and Goldfine, A. B., Inflammation and insulin resistance. J. Clin. Invest. 2006. 116: 1793–1801.
2. Lumeng, C. N. and Saltiel, A. R., Inflammatory links between obesity and metabolic disease. J. Clin. Invest. 2011. 121: 2111–2117.
3. Gregor, M. F. and Hotamisligil, G. S., Inflammatory mechanisms in obesity. Annu. Rev. Immunol. 2011. 29: 415–445.
4. WHO, Diabetes Fact Sheet, http://www.who.int/mediacentre/factsheets/fs312/en/ 2017.
5. Mathers, C. D. and Loncar, D., Projections of global mortality and burden of disease from 2002 to 2030. PLOS Med. 2006. 3: e442.
6. Larson, G. L. and Henson, P. M., Mediators of inflammation. Annu. Rev. Immunol. 1983. 1: 335–359.
7. Hotamisligil, G. S., Inflammation and metabolic disorders. Nature 2006. 444: 860–867.
8. Ussar, S., Lee, K. Y., Dankel, S. N., Boucher, J., Haering, M.-F., Kleinridders, A., Thomou, T. et al., ASC-1, PAT2, and P2RX5 are cell surface markers for white, beige and brown adipocytes. Sci. Trans. Med. 2014. 6: 1–10.
9. Rosen, E. D. and Spiegelman, B. M., What we talk about when we talk about fat. Cell 2014. 156: 20–44.
10. Kissig, M., Shapira, S. N. and Seale, P., SnapShot: brown and beige adipose thermogenesis. Cell 2016. 166: 258–258 e251.
11. Rothwell, N. J. and Stock, M. J., A role for brown adipose tissue in diet-induced thermogenesis. Nature 1979. 281: 31–35.
12. Kälin, S., Heppner, F. L., Bechmann, I., Prinz, M., Tschop, M. H. and Yi, C. X., Hypothalamic innate immune reaction in obesity. Nat. Rev. Endocrinol. 2015. 11: 339–351.
13. Thaler, J. P., Yi, C. X., Schur, E. A., Guyenet, S. J., Hwang, B. H., Dietrich, M. O., Zhao, X. et al., Obesity is associated with hypothalamic injury in rodents and humans. J. Clin. Invest. 2012. 122: 153–162.
14. Clemmensen, C., Muller, T. D., Woods, S. C., Berthoud, H. R., Seeley, R. J. and Tschop, M. H., Gut-brain cross-talk in metabolic control. Cell 2017. 168: 758–774.
15. Kanneganti, T. D. and Dixit, V. D., Immunological complications of obesity. Nat. Immunol. 2012. 13: 707–712.
16. Morris, D. L., Cho, K. W., Delproposto, J. L., Oatmen, K. E., Geletka, L. M., Martinez-Santibanez, G., Singer, K. et al., Adipose tissue macrophages function as antigen-presenting cells and regulate adipose tissue CD4+ T cells in mice. Diabetes 2013. 62: 2762–2772.
17. Mathis, D., Immunological goings-on in visceral adipose tissue. Cell Metab. 2013. 17: 851–859.
18. O'Sullivan, T. E., Rapp, M., Fan, X., Weizman, O. E., Bhardwaj, P., Adams, N. M., Walzer, T. et al., Adipose-resident Group 1 innate lymphoid cells promote obesity-associated insulin resistance. Immunity 2016. 45: 428–441.
19. Boulenouar, S., Michelet, X., Duquette, D., Alvarez, D., Hogan, A. E., Dold, C., O'Connor, D. et al., Adipose type one innate lymphoid cells regulate macrophage homeostasis through targeted cytotoxicity. Immunity 2017. 46: 273–286.
20. Molofsky, A. B., Nussbaum, J. C., Liang, H. E., Van Dyken, S. J., Cheng, L. E., Mohapatra, A., Chawla, A. et al., Innate lymphoid type 2 cells sustain visceral adipose tissue eosinophils and alternatively activated macrophages. J. Exp. Med. 2013. 210: 535–549.
21. Wu, D., Molofsky, A. B., Liang, H.-E., Ricardo-Gonzalez, R. R., Jouihan, H. A., Bando, J. K., Chawla, A. et al., Eosinophils sustain adipose alternatively activated macrophages associated with glucose homeostasis. Science 2011. 332: 243.
22. Han, J. M. and Levings, M. K., Immune regulation in obesity-associated adipose inflammation. J. Immunol. 2013. 191: 527–532.
23. Panduro, M., Benoist, C. and Mathis, D., Tissue tregs. Annu. Rev. Immunol. 2016. 34: 609–633.
24. DiSpirito, J. R. and Mathis, D., Immunological contributions to adipose tissue homeostasis. Sem. Immunol. 2015. 27: 315–321.
25. Wensveen, F. M., Valentic, S., Sestan, M., Turk Wensveen, T. and Polic, B., The “Big Bang” in obese fat: events initiating obesity-induced adipose tissue inflammation. Eur. J. Immunol. 2015. 45: 2446–2456.
26. Osborn, O. and Olefsky, J. M., The cellular and signaling networks linking the immune system and metabolism in disease. Nat. Med. 2012. 18: 363–374.
27. Lord, G. M., Matarese, G., Howard, J. K., Baker, R. J., Bloom, S. R. and Lechler, R. I., Leptin modulates the T-cell immune response and reverses starvation-induced immunosuppression. Nature 1998. 394: 897–901.
28. Santos-Alvarez, J., Goberna, R. and Sanchez-Margalet, V., Human leptin stimulates proliferation and activation of human circulating monocytes. Cell Immunol. 1999. 194: 6–11.
29. Kumada, M., Kihara, S., Ouchi, N., Kobayashi, H., Okamoto, Y., Ohashi, K., Maeda, K. et al., Adiponectin specifically increased tissue inhibitor of metalloproteinase-1 through interleukin-10 expression in human macrophages. Circulation 2004. 109: 2046–2049.
30. Yamaguchi, N., Argueta, J. G., Masuhiro, Y., Kagishita, M., Nonaka, K., Saito, T., Hanazawa, S. et al., Adiponectin inhibits Toll-like receptor family-induced signaling. FEBS Lett. 2005. 579: 6821–6826.
31. Ouchi, N., Parker, J. L., Lugus, J. J. and Walsh, K., Adipokines in inflammation and metabolic disease. Nat. Rev. Immunol. 2011. 11: 85–97.
32. Cipolletta, D., Adipose tissue-resident regulatory T cells: phenotypic specialization, functions and therapeutic potential. Immunology 2014. 142: 517–525.
33. Wang, B., Jenkins, J. R. and Trayhurn, P., Expression and secretion of inflammation-related adipokines by human adipocytes differentiated in culture: integrated response to TNF-alpha. Am. J. Physiol. Endocrinol. Metab. 2005. 288: E731-E740.
34. Berg, A. H. and Scherer, P. E., Adipose tissue, inflammation, and cardiovascular disease. Circ. Res. 2005. 96: 939–949.
35. Allan, S. E., Crome, S. Q., Crellin, N. K., Passerini, L., Steiner, T. S., Bacchetta, R., Roncarolo, M. G. et al., Activation-induced FOXP3 in human T effector cells does not suppress proliferation or cytokine production. Int. Immunol. 2007. 19: 345–354.
36. Matarese, G., Procaccini, C., De Rosa, V., Horvath, T. L. and La Cava, A., Regulatory T cells in obesity: the leptin connection. Trends Mol. Med. 2010. 16: 247–256.
37. Winer, S., Chan, Y., Paltser, G., Truong, D., Tsui, H., Bahrami, J., Dorfman, R. et al., Normalization of obesity-associated insulin resistance through immunotherapy. Nat. Med. 2009. 15: 921–929.
38. Tiemessen, M. M., Jagger, A. L., Evans, H. G., van Herwijnen, M. J., John, S. and Taams, L. S., CD4+CD25+Foxp3+ regulatory T cells induce alternative activation of human monocytes/macrophages. Proc. Natl. Acad. Sci. USA 2007. 104: 19446–19451.
39. Han, J. M., Patterson, S. J., Speck, M., Ehses, J. A. and Levings, M. K., Insulin inhibits IL-10-mediated regulatory T cell function: implications for obesity. J. Immunol. 2014. 192: 623–629.
40. Han, J. M., Wu, D., Denroche, H. C., Yao, Y., Verchere, C. B. and Levings, M. K., IL-33 Reverses an obesity-induced deficit in visceral adipose tissue ST2+ T regulatory cells and ameliorates adipose tissue inflammation and insulin resistance. J. Immunol. 2015. 194: 4777–4783.
41. Feuerer, M., Herrero, L., Cipolletta, D., Naaz, A., Wong, J., Nayer, A., Lee, J. et al., Lean, but not obese, fat is enriched for a unique population of regulatory T cells that affect metabolic parameters. Nat. Med. 2009. 15: 930–939.
42. Cipolletta, D., Cohen, P., Spiegelman, B. M., Benoist, C. and Mathis, D., Appearance and disappearance of the mRNA signature characteristic of Treg cells in visceral adipose tissue: age, diet, and PPARgamma effects. Proc. Natl. Acad. Sci. USA 2015. 112: 482–487.
43. Cipolletta, D., Feuerer, M., Li, A., Kamei, N., Lee, J., Shoelson, S. E., Benoist, C. et al., PPAR-gamma is a major driver of the accumulation and phenotype of adipose tissue Treg cells. Nature 2012. 486: 549–553.
44. Eller, K., Kirsch, A., Wolf, A. M., Sopper, S., Tagwerker, A., Stanzl, U., Wolf, D. et al., Potential role of regulatory T cells in reversing obesity-linked insulin resistance and diabetic nephropathy. Diabetes 2011. 60: 2954–2962.
45. Tontonoz, P., Hu, E. and Spiegelman, B. M., Stimulation of adipogenesis in fibroblasts by PPARγ2, a lipid-activated transcription factor. Cell 1994. 79: 1147–1156.
46. Bapat, S. P., Myoung Suh, J., Fang, S., Liu, S., Zhang, Y., Cheng, A., Zhou, C. et al., Depletion of fat-resident Treg cells prevents age-associated insulin resistance. Nature 2015. 528: 137–141.
47. Wernstedt Asterholm, I., Tao, C., Morley, T. S., Wang, Q. A., Delgado-Lopez, F., Wang, Z. V. and Scherer, P. E., Adipocyte inflammation is essential for healthy adipose tissue expansion and remodeling. Cell Metab. 2014. 20: 103–118.
48. Schmitz, J., Owyang, A., Oldham, E., Song, Y., Murphy, E., McClanahan, T. K., Zurawski, G. et al., IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity 2005. 23: 479–490.
49. Liew, F. Y., Girard, J. P. and Turnquist, H. R., Interleukin-33 in health and disease. Nat. Rev. Immunol. 2016. 16: 676–689.
50. Cayrol, C. and Girard, J. P., IL-33: an alarmin cytokine with crucial roles in innate immunity, inflammation and allergy. Curr. Opin. Immunol. 2014. 31: 31–37.
51. Yanagisawa, K., Takagi, T., Tsukamoto, T., Tetsuka, T. and Tominaga, S.-I., Presence of a novel primary response gene ST2L, encoding a product highly similar to the interleukin 1 receptor type 1. FEBS Lett. 1993. 318: 83–87.
52. Hayakawa, H., Hayakawa, M., Kume, A. and Tominaga, S., Soluble ST2 blocks interleukin-33 signaling in allergic airway inflammation. J. Biol. Chem. 2007. 282: 26369–26380.
53. Wood, I. S., Wang, B. and Trayhurn, P., IL-33, a recently identified interleukin-1 gene family member, is expressed in human adipocytes. Biochem. Biophys. Res. Commun. 2009. 384: 105–109.
54. Molofsky, A. B., Savage, A. K. and Locksley, R. M., Interleukin-33 in tissue homeostasis, injury, and inflammation. Immunity 2015. 42: 1005–1019.
55. Vasanthakumar, A., Moro, K., Xin, A., Liao, Y., Gloury, R., Kawamoto, S., Fagarasan, S. et al., The transcriptional regulators IRF4, BATF and IL-33 orchestrate development and maintenance of adipose tissue-resident regulatory T cells. Nat. Immunol. 2015. 16: 276–285.
56. Schiering, C., Krausgruber, T., Chomka, A., Frohlich, A., Adelmann, K., Wohlfert, E. A., Pott, J. et al., The alarmin IL-33 promotes regulatory T-cell function in the intestine. Nature 2014. 513: 564–568.
57. Duan, L., Chen, J., Zhang, H., Yang, H., Zhu, P., Xiong, A., Xia, Q. et al., Interleukin-33 ameliorates experimental colitis through promoting Th2/Foxp3(+) regulatory T-cell responses in mice. Mol. Med. 2012. 18: 753–761.
58. Turnquist, H. R., Zhao, Z., Rosborough, B. R., Liu, Q., Castellaneta, A., Isse, K., Wang, Z. et al., IL-33 expands suppressive CD11b+ Gr-1(int) and regulatory T cells, including ST2L+ Foxp3+ cells, and mediates regulatory T cell-dependent promotion of cardiac allograft survival. J. Immunol. 2011. 187: 4598–4610.
59. Matta, B. M., Lott, J. M., Mathews, L. R., Liu, Q., Rosborough, B. R., Blazar, B. R. and Turnquist, H. R., IL-33 is an unconventional Alarmin that stimulates IL-2 secretion by dendritic cells to selectively expand IL-33R/ST2+ regulatory T cells. J. Immunol. 2014. 193: 4010–4020.
60. Miller, A. M., Asquith, D. L., Hueber, A. J., Anderson, L. A., Holmes, W. M., McKenzie, A. N., Xu, D. et al., Interleukin-33 induces protective effects in adipose tissue inflammation during obesity in mice. Circ. Res. 2010. 107: 650–658.
61. Brestoff, J. R., Kim, B. S., Saenz, S. A., Stine, R. R., Monticelli, L. A., Sonnenberg, G. F., Thome, J. J. et al., Group 2 innate lymphoid cells promote beiging of white adipose tissue and limit obesity. Nature 2015. 519: 242–246.
62. Lynch, L., O'Shea, D., Winter, D. C., Geoghegan, J., Doherty, D. G. and O'Farrelly, C., Invariant NKT cells and CD1d(+) cells amass in human omentum and are depleted in patients with cancer and obesity. Eur. J. Immunol. 2009. 39: 1893–1901.
63. Wouters, K., Gaens, K., Bijnen, M., Verboven, K., Jocken, J., Wetzels, S., Wijnands, E. et al., Circulating classical monocytes are associated with CD11c+ macrophages in human visceral adipose tissue. Sci. Rep. 2017. 7: 42665.
64. Duffaut, C., Zakaroff-Girard, A., Bourlier, V., Decaunes, P., Maumus, M., Chiotasso, P., Sengenes, C. et al., Interplay between human adipocytes and T lymphocytes in obesity: CCL20 as an adipochemokine and T lymphocytes as lipogenic modulators. Arterioscler. Thromb. Vasc. Biol. 2009. 29: 1608–1614.
65. Deiuliis, J., Shah, Z., Shah, N., Needleman, B., Mikami, D., Narula, V., Perry, K. et al., Visceral adipose inflammation in obesity is associated with critical alterations in tregulatory cell numbers. PLoS One 2011. 6: e16376.
66. Travers, R. L., Motta, A. C., Betts, J. A., Bouloumie, A. and Thompson, D., The impact of adiposity on adipose tissue-resident lymphocyte activation in humans. Int. J. Obes. (Lond) 2015. 39: 762–769.
67. Bertola, A., Ciucci, T., Rousseau, D., Bourlier, V., Duffaut, C., Bonnafous, S., Blin-Wakkach, C. et al., Identification of adipose tissue dendritic cells correlated with obesity-associated insulin-resistance and inducing Th17 responses in mice and patients. Diabetes 2012. 61: 2238–2247.
68. Fabbrini, E., Cella, M., McCartney, S. A., Fuchs, A., Abumrad, N. A., Pietka, T. A., Chen, Z. et al., Association between specific adipose tissue CD4+ T-cell populations and insulin resistance in obese individuals. Gastroenterology 2013. 145: 366–374 e361-363.
69. Ioan-Facsinay, A., Kwekkeboom, J. C., Westhoff, S., Giera, M., Rombouts, Y., van Harmelen, V., Huizinga, T. W. et al., Adipocyte-derived lipids modulate CD4+ T-cell function. Eur. J. Immunol. 2013. 43: 1578–1587.
70. Dalmas, E., Venteclef, N., Caer, C., Poitou, C., Cremer, I., Aron-Wisnewsky, J., Lacroix-Desmazes, S. et al., T cell-derived IL-22 amplifies IL-1beta-driven inflammation in human adipose tissue: relevance to obesity and type 2 diabetes. Diabetes 2014. 63: 1966–1977.
71. Pereira, S., Teixeira, L., Aguilar, E., Oliveira, M., Savassi-Rocha, A., Pelaez, J. N., Capettini, L. et al., Modulation of adipose tissue inflammation by FOXP3+ Treg cells, IL-10, and TGF-beta in metabolically healthy class III obese individuals. Nutrition 2014. 30: 784–790.
72. Zeyda, M., Huber, J., Prager, G. and Stulnig, T. M., Inflammation correlates with markers of T-cell subsets including regulatory T cells in adipose tissue from obese patients. Obesity (Silver Spring) 2011. 19: 743–748.
73. McLaughlin, T., Liu, L. F., Lamendola, C., Shen, L., Morton, J., Rivas, H., Winer, D. et al., T-cell profile in adipose tissue is associated with insulin resistance and systemic inflammation in humans. Arterioscler. Thromb. Vasc. Biol. 2014. 34: 2637–2643.
74. Zeyda, M., Wernly, B., Demyanets, S., Kaun, C., Hammerle, M., Hantusch, B., Schranz, M. et al., Severe obesity increases adipose tissue expression of interleukin-33 and its receptor ST2, both predominantly detectable in endothelial cells of human adipose tissue. Int. J. Obes. (Lond) 2013. 37: 658–665.
75. Thome, J. J., Bickham, K. L., Ohmura, Y., Kubota, M., Matsuoka, N., Gordon, C., Granot, T. et al., Early-life compartmentalization of human T cell differentiation and regulatory function in mucosal and lymphoid tissues. Nat. Med. 2016. 22: 72–77.
76. Williamson, R. T., On the treatment of glycosuria and diabetes mellitus with sodium salicylate. Br. Med. J. 1901. 1: 760–762.
77. Yuan, M., Konstantopoulos, N., Lee, J., Hansen, L., Li, Z.-W., Karin, M. and Shoelson, S. E., Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of Ikkβ. Science 2001. 293: 1673–1677.
78. Ilan, Y., Maron, R., Tukpah, A. M., Maioli, T. U., Murugaiyan, G., Yang, K., Wu, H. Y. et al., Induction of regulatory T cells decreases adipose inflammation and alleviates insulin resistance in ob/ob mice. Proc. Natl. Acad. Sci. USA 2010. 107: 9765–9770.
79. Van Gool, F., Molofsky, A. B., Morar, M. M., Rosenzwajg, M., Liang, H. E., Klatzmann, D., Locksley, R. M. et al., Interleukin-5-producing group 2 innate lymphoid cells control eosinophilia induced by interleukin-2 therapy. Blood 2014. 124: 3572–3576.
80. Strissel, K. J., Stancheva, Z., Miyoshi, H., Perfield, J. W., 2nd., DeFuria, J., Jick, Z., Greenberg, A. S. et al., Adipocyte death, adipose tissue remodeling, and obesity complications. Diabetes 2007. 56: 2910–2918.
81. Huehn, J. and Beyer, M., Epigenetic and transcriptional control of Foxp3+ regulatory T cells. Sem. Immunol. 2015. 27: 10–18.